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Abstract
BACKGROUND: Classic dynamic hepatobiliary scintigraphy 
(DHBS) is commonly performed with 99mTc-Iminodiacetic Acid 
(IDA) derivatives and represents a non-invasive diagnosis meth-
od for biliary dyskinesia, fistulas, surgical anastomosis, etc (1). 
This study assesses the possibility of performing DHBS with 
99mTc-Tetrofosmine (TF), a radiopharmaceutical (RF) dedicated 
to myocardial perfusion scintigraphy (MPS), but being excreted 
through the liver. The possibility to use 99mTc-TF for DHBS may 
be important in situations when the standardized RF for this 
procedure (IDA derivatives) is not available. 
MATERIAL AND METHODS: We performed DHBS for 30 pa-
tients referred for investigation by internal medicine and surgery 
departments. The patients had been fasting for12 hours. The 
dynamic investigation started simultaneously with the intrave-
nous (IV) administration of 37–110 MBq (1–3 mCi) 99mTc-TF. 
Dynamic images were recorded for 30–45 minutes, one image 
per minute, followed by static scintigraphy at 1 h, 1.5 h, 2 h, 
and 3 h after IV injection. 
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RESULTS: The quality of scintigraphic images of the liver and 
biliary tree obtained at DHBS with 99mTc-TF ensured the correct 
diagnosis of biliary dyskinesia, stasis, stenosis, and fistulas. 
CONCLUSIONS: DHBS using 99mTc-TF is justified by the image 
quality and by the good cost/benefits ratio. Because the IDA 
derivatives are not always available, this finding may be impor-
tant for medical practice. 99mTc-TF evacuated through the bile 
duct allows DHBS interpretation, while the necessary dose is 
approximately 8 to 20 times smaller than that used for myocardial 
perfusion scintigraphy. 
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Introduction
Classically performed DHBS is based on the pharmacokinet-
ics of -Hydroxy Iminodiacetic Acid (HIDA) and similar derivatives of 
IDA [1]. After IV administration, 99mTc-HIDA is rapidly accumulated in 
the liver and after a short intrahepatic transit time, the RF is excreted 
(the same as the molecular complexes with molecular mass higher 
than 300) through the biliary system into the duodenum [1]. About 
85–90% of 99mTc-HIDA is eliminated through the liver, the percentage 
depending on the status of hepatocyte function [2]. 
Scintigraphic images are recorded for 45–60 min, 1 image 
for each 2 minutes, the recording starting simultaneously with IV 
injection of RF [1].
The liver is visualized with 99mTc-HIDA in normal cases within 
0–5 min after IV injection, the common biliary duct — within 
5–20 min, gallbladder — within 10–40 min, duodenum — within 
15–45 min, and the kidneys — within 0–5 min [2].
In the past few years, the Romanian market of RF prod-
ucts was limited due to economic reasons and legislative gaps. 
In this context, IDA derivatives have not been available for DHBS 
investigations for more than 5 years. This study is a result of our 
efforts to maximally use the potential of the pharmaceuticals which 
are still available, in order to perform certain investigations which 
otherwise would not be possible.
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The visualization of liver and extrahepatic bile ducts using-
99mTc-TF for MPS has its inconveniences. However, it challenged 
us to test the possible assessment of the biliary tree using TF.
In our desire to perform DHBS using TF, we also referred to the 
studies aimed at increasing the quality of MPS by accelerating the 
biological clearance of 99mTc-TF through the hepatic bile tree using 
a high fat lunch, milk, lemon juice, etc [5–14, 16–18].
Hepatic tumours and impairment of bile drainage were only 
incidentally reported when performing MPS with TF [11–13, 19, 20].
Material and methods 
Radiopharmaceutical
TF (Myoview) is a pharmaceutical commonly used for 
myocardial perfusion studies after radioactive marking with 99mTc. 
Its active substance is sodium TF [6,9-bis(2-ethoxyethyl)-3,12-di-
oxa-6,9-diphosphatetradecane], C18H40O4P2, in a concentration 
of 0.23 mg/bottle [3]. The product is created for IV administra-
tion to patients after reconstitution is obtained by adding sodium 
pertechnetate (Na99mTcO4) to the bottle. The radioactive marking 
of TF results from the oxidation-reduction reaction with sodium 
pertechnetate in the presence of stannous chloride (SnCl22H2O) [3].
TF is captured during the first passage by the myocardium 
cells, with an extraction rate of about 40%. The tracer remaining in 
circulation is extracted mostly by the hepatic parenchyma (at the 
level of hepatocytes) and afterwards it is evacuated it follows the 
bile tree (being a lipophilic complex with molecular mass 895), 
with less than 15% being eliminated through the kidneys [3, 4, 
22]. In our study the right kidney image has shown to be an in-
convenient due to its. 
The time of appearance of TF in different parts of the bile tree 
has not been standardized yet. Because the common bile duct 
area is usually placed over the right kidney region, recording the 
dynamic parameters for the common bile duct is of less importance 
than identification of stasis.
Patient characteristics
We examined a total of 30 patients aged 58.4 ± 11.2 years, 
8 men and 22 women.
Fourteen patients were normal controls aged 38.5 ± 9.5 years, 
investigated in order to establish the basic aspect of the investiga-
tion. Ten of them were referred to our department for MPS without 
having liver or biliary illness.
Scintigraphy protocol 
The patients were fasted for 12 hours before the examination 
so as not to influence the biological clearance of 99mTc-TF. The 
cases were referred for investigation by the internal medicine 
and surgery departments of our hospital. We were not involved 
in the selection. 
The investigations were performed with a SPECT Orbiter Sie-
mens gamma-camera equipped with a low-energy, high-resolution, 
parallel collimator. The acquisition and processing of data were 
performed using a Power MacIntosh computer connected to the 
gamma-camera, using the ICON programs designed for scintig-
raphy investigations.
In order to perform DHBS, we respected the preparation pro-
cedure of 99mTc-TF as indicated in the product’s prospectus. The 
RF administration to patients was done via IV injection in doses of 
37–110 MBq (1–3 mCi), depending on the patient’s weight. 
The dynamic scintigraphy images were acquired during 
30–45 min, starting at the moment of RT IV injection, one image 
per minute, in the anterior view. We decreased the time for each 
image as compared to DHBS with HIDA (1 image/min) instead 
of 1 image/2 min, in order to obtain a better sensitivity. The pa-
tients were placed in the supine position since the investigation 
involved the hepatic and intestinal areas. Static scintigraphy ima-
ges of the abdomen area were acquired at 1 h, 1.5 h, 2 h, and 3 h 
post-injection, after the dynamic acquisition of data.
All scintigraphic investigations presented in this study were 
performed at the Nuclear Medicine Laboratory of the Clinical 
Emergency Hospital “Prof. Dr. O. Fodor” Cluj-Napoca, by the 
same team.
The radioactive marking of the pharmaceutical product, ac-
quisition of data, and compliance of radiological security condi-
tions were performed by the laboratory’s physicist. The interpreta-
tion of images was made by our department’s medical doctor.
Radiation dosimetry
In order to introduce into use a new investigation based on 
a radiopharmaceutical already approved for another type of scin-
tigraphy, it is absolutely necessary to respect the radioprotection 
of patients and medical personal according to ALARA (As Low 
As Reasonably Achievable) principles.
Because 99mTc-TF is a radiotracer widely used for MPS, 
its dosimetry is standardized for the higher doses used in MPS 
[3]. The gallbladder walls absorb the highest doses, followed by 
the intestine [3]. 
Because the doses which we used at DHBS were 8–20 
times smaller than at MPS, internal irradiation is also lower than 
during MPS, which had already been shown as respecting ALARA 
principles. This fact justifies the use of TF for DHBS in a radiopro-
tection point of view, in addition to the favourable ratio between 
irradiation and diagnosis benefit. 
Results
Comparing the scintigraphy images at DHBS using 99mTc-TF 
with those which we have in our laboratory database, obtained 
with 99mTc-HIDA, we have been able to show that the resolution 
of scintigraphic images with 99mTc-TF allows the visualization of 
intrahepatic and extrahepatic bile tree. After the injection of 37 
MBq 99mTc-TF the bile ducts of the left and right lobes, biliary 
confluent, common bile duct, and gallbladder can be visualized 
accurately. The stasis is easy to detect both the intrahepatic and 
extrahepatic bile tree. 
The quantity of RF eliminated through the liver is enough to 
allow an increase in the region of interest of dynamic curves having 
low amplitude fluctuations. 
Visualization of the myocardial area is not an impediment in 
interpretation of DHBS with 99mTc-TF and does not impose higher 
doses than at DHBS with 99mTc-HIDA.
Normal aspect
In normal patients, maximum amplitude of liver curve occurred 
at 10 ± 5 min. The half-time of the liver curve amplitude (calculated 
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on extrapolated histogram) was at 60 ± 12 min after injection. The 
left lobe biliary duct was visualized at 21 ± 4 min. The right lobe 
biliary duct is commonly difficult to see because of gallbladder 
and right kidney superposition.
In 8 normal cases (without clinical dyskinesia symptoms), the 
duodenum was not visualized at 45 min and 1 h after the injection. 
The gallbladder was visualized starting with 28 ± 7 min after 
the injection. 
Pathological aspects
Table I presents the pathological cases. For two patients with 
clinic biliary dyskinesia, DHBS showed normal aspect.
The other 14 patients referred to us for DHBS had abnormal 
dynamic findings.
Ten patients with clinical diagnosis of biliary dyskinesia had 
the following particularities:
—  in 6 cases the gallbladder was not visualized during the 
dynamic investigation and on 1h post-injection static image. 
For 2 of these, the gallbladder also did not appear on static 
images recorded at 1.5 h, 2 h, and 3 h, while for 4 of them the 
gall bladder could only be visualized on static images at 2 h 
and 3 h (Figures 1, 2). Clinical diagnosis of acute cholecysti-
tis was excluded for those patients.
One patient had important stasis on the biliary confluent area 
and partly in the left lobe bile duct.
For two patients the tracer arrived to the gallbladder in 
due time, but its excretion in the duodenum at 45 minutes and 
1 h post-injection was very small, although no stasis or obstacle 
was found 
One patient had an incomplete obstacle at the level of the 
junction of the cystic duct with the common biliary duct. ERCP 
confirmed this diagnosis (Figure 3).
We also investigated two post-surgery patients suspected of 
having fistulas: one of them with bilio-intestinal fistula (Figure 4) 
and the other with bilio-bronchial fistula. For the both of them, 
DHBS highlighted RF stasis at the origin point of the fistula and 
pathological dynamic of RF determined by the fistula. The thin 
trajectory of fistulas could not be visualized.
Another case was of a 52-year-old woman who had a defective 
uptake of tracer in the hilum area  liver scintigraphy with radio-
colloid. DHBS detected a dilation of intrahepatic biliary tree with 
important stasis in the biliary confluent area (Figure 5).
For a patient diagnosed clinically with common bile duct 
obstructed by a bile stone, DHBS showed a dilated common bile 
duct, most probably due to an incomplete obstacle at the level 
of the Oddi sphincter. This diagnosis was confirmed by ERCP.
The dynamic liver aspect for an asymptomatic patient is shown 
in Figure 6. The liver curve reaches its highest amplitude at 
10 min post-injection. Half of the liver curve amplitude calculated 
Table I. Pathologic cases
Referral diagnosis No patients Females Males Normal aspect 
on scintigraphy
Pathologic 
scintigraphic results
Biliary dyskinesia 12 10 2 2 10
Post-anastomotic fistula 1 1 – – 1
Lack of  colloidal tracer on liver 
scintigraphy in biliary confluent area
1 1 – – 1
Common bile duct stenosis 1 1 – – 1
Figure 1. Biliary dyskinesia with lack of gallbladder drainage and bile stasis in the common bile duct.
Figure 2. Biliary dyskinesia — static images at 3 hours after injection 
with remnant tracer in the gallbladder.
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by extrapolation is at 50 minutes post-injection (half-time of the 
liver = 40 min). There was no tracer in the gut area at 45 min 
after injection. The tracer arrived at the gallbladder at 28 min 
post-injection, without emptying at 45 min post-injection (gallblad-
der curve is not presented in the image due to its considerably 
higher amplitude than that of the liver).
Discussion 
DHBS with 99mTc-HIDA was performed in our laboratory until 
2005. Since then, HIDA and other IDA derivatives have been no 
longer available on the Romanian RF market. Consequently, we 
were not able to answer requests for DHBS, leaving us compelled 
to find a solution to be able to again perform such investigations. 
Use of TF as RF for DHBS has been based on its pharma-
cokinetics involving excretion through the liver and biliary tree.
After introducing 99mTc-TF in the practice of our laboratory (for 
MPS and parathyroid scintigraphy) we have been able to verify the 
good resolution of images of the liver and biliary tree area during 
these standard investigations. 
The bibliography includes several studies related to the 
opportunity to influence the time of evacuation from the 
liver of 99mTc-TF at MPS using different types of foods [5–11, 
16–18].
We found information about several cases of liver or biliary 
pathology incidentally reported at MPS [11–13, 19, 20]. Some later 
studies used TF to determine ejection fraction of the gallbladders of 
patients referred for MPS [21].
Figure 3. Stasis in the common bile duct.
Figure 5. Transient stasis in the common bile duct with delayed tracer drainage in the gut.
Figure 4. Bilio-intestinal fistula — static images at 1 hour and 2 hours after injection.
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Figure 6. Dynamic hepato-biliary scintigraphy for an asymptomatic woman, 35-years-old.
Because the tracer 99mTc-TF is the first-choice for MPS and it 
is currently used for this investigation, performing DHBS by using 
residual tracer from MPS has great advantages in an economical 
point of view.
Due to the fact that the RF used does not contain iodine, 
DHBS with 99mTc-TF may be performed in allergic patients in whom 
iodine-based radiological contrast agents cannot be used.
From a radioprotection point of view, use of TF for DHBS 
respects irradiation limits.
We were therefore able to be of help with scintigraphy diagno-
sis for various dyskinesia cases, biliary fistulas, biliary stasis, and 
common bile duct stenosis.
Conclusions
Biliary drainage of 99mTc-TF allows the acquisition of good qual-
ity images of the intra-hepatic bile tree, common bile duct, and 
gallbladder. The good resolution of images allows identification 
of intra- and extrahepatic stasis areas, as well as the dynamics of 
tracer at their level.
 The tracer quantity evacuated in the bile tree is enough to al-
low rising dynamic curves with good resolution. The dynamics of 
99mTc-TF allows late visualization of bile tracts, up to 3 hours after 
the injection.
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